VEGF, VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients treated with thalidomide-based regimens

por Lopes-Aguiar, L, Delamain, M T, Brito, A B C, Lourenço, G J, Costa, E F D, Oliveira, G B, Vassallo, J, De Souza, C A, Lima, C S P
Publicado 2017